Latest Breaking News On - Strategikon pharma - Page 1 : comparemela.com

Venture Madness Selects 17 Companies as Finalists for their Annual Competition

/PRNewswire/ Venture Madness by Invest Southwest has selected 17 finalists for the 2023 Venture Madness Competition. Finalists were selected by judges from.

First-to-Market Vendor Management Application for Pharma R&D

/PRNewswire/ Strategikon Pharma announced today they are adding a new application to complete the Clinical Maestro® Sponsor Edition platform- VISION for R&D.

First-to-Market Vendor Management Application for Pharma R&D

/PRNewswire/ Strategikon Pharma announced today they are adding a new application to complete the Clinical Maestro® Sponsor Edition platform- VISION for R&D.

Clinical Maestro 2.4 Brings New Speed and Agility to Clinical Trial Budgeting and Outsourcing

Strategikon Pharma Announces Close of Series A Financing

Strategikon Pharma Announces Close of Series A Financing News provided by Share this article Share this article SAN FRANCISCO, April 22, 2021 /PRNewswire/ Strategikon Pharma, a leader in digital business technology to accelerate planning, budgeting, and outsourcing for clinical trials, announced the closing of Series A financing. The round was led by Osage Venture Partners in partnership with Wing Venture Capital and Bascom Ventures. These firms add to previous high caliber investors including Life Science Angels, Band of Angels, Tech Coast Angels, Golden Seeds and Saratoga Ventures, Inc. As the organization continues to grow, the new capital will be used to increase Strategikon s global footprint in Europe and Asia, develop new and enhance existing applications in the company s flagship Clinical Maestro™ ecosystem, and expand the breadth and depth of professional services to provide best-in-class customer experience and support.